Spark Therapeutics
VerifiedA fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$4.3b (Public information from Feb 2019)
Philadelphia Pennsylvania (HQ)
Deals in current and previous year:
No columns specified